Late-onset group B streptococcal meningitis complicated with extensive cerebral infarction
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cho, M.S. | - |
dc.contributor.author | Kim, Y. | - |
dc.contributor.author | Cho, H.-K. | - |
dc.contributor.author | Choi, S.-H. | - |
dc.date.available | 2020-02-27T12:42:29Z | - |
dc.date.created | 2020-02-12 | - |
dc.date.issued | 2018 | - |
dc.identifier.issn | 2384-1079 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/4266 | - |
dc.description.abstract | Group B streptococcus (GBS) is the leading cause of neonatal morbidity and mortality. Late-onset GBS disease commonly manifests as occult bacteremia or meningitis. Approximately 50% of survivors of late-onset meningitis have long-term neurologic sequelae. Cerebrovascular complications are often associated with unfavorable clinical outcomes of GBS meningitis. There have been a few reports of cerebral infarction accompanied by GBS meningitis. We report a 29-day-old girl with severe, widespread cerebral infarction due to late-onset GBS meningitis. Isolated GBS strain from this patient was serotype III, ST-19. Currently, she has cortical blindness and significant developmental delay. © 2018, The Korean Society of Pediatric Infectious Diseases. All rights reserved. | - |
dc.language | 한국어 | - |
dc.language.iso | ko | - |
dc.publisher | The Korean Society of Pediatric Infectious Diseases | - |
dc.relation.isPartOf | Pediatric Infection and Vaccine | - |
dc.subject | Article | - |
dc.subject | bacterial strain | - |
dc.subject | bacterium isolation | - |
dc.subject | brain infarction | - |
dc.subject | case report | - |
dc.subject | cerebral blindness | - |
dc.subject | clinical article | - |
dc.subject | developmental delay | - |
dc.subject | disease severity | - |
dc.subject | female | - |
dc.subject | group B streptococcal meningitis | - |
dc.subject | human | - |
dc.subject | newborn | - |
dc.subject | onset age | - |
dc.title | Late-onset group B streptococcal meningitis complicated with extensive cerebral infarction | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.doi | 10.14776/piv.2018.25.1.45 | - |
dc.identifier.bibliographicCitation | Pediatric Infection and Vaccine, v.25, no.1, pp.45 - 49 | - |
dc.identifier.kciid | ART002337689 | - |
dc.identifier.scopusid | 2-s2.0-85046107422 | - |
dc.citation.endPage | 49 | - |
dc.citation.startPage | 45 | - |
dc.citation.title | Pediatric Infection and Vaccine | - |
dc.citation.volume | 25 | - |
dc.citation.number | 1 | - |
dc.contributor.affiliatedAuthor | Cho, H.-K. | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Cerebral infarction | - |
dc.subject.keywordAuthor | Meningitis | - |
dc.subject.keywordAuthor | Neonatal sepsis | - |
dc.subject.keywordAuthor | Streptococcus agalactiae | - |
dc.subject.keywordPlus | Article | - |
dc.subject.keywordPlus | bacterial strain | - |
dc.subject.keywordPlus | bacterium isolation | - |
dc.subject.keywordPlus | brain infarction | - |
dc.subject.keywordPlus | case report | - |
dc.subject.keywordPlus | cerebral blindness | - |
dc.subject.keywordPlus | clinical article | - |
dc.subject.keywordPlus | developmental delay | - |
dc.subject.keywordPlus | disease severity | - |
dc.subject.keywordPlus | female | - |
dc.subject.keywordPlus | group B streptococcal meningitis | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | newborn | - |
dc.subject.keywordPlus | onset age | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.